about
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Enabling anticancer therapeutics by nanoparticle carriers: the delivery of PaclitaxelRecent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryThe application of carbon nanotubes in target drug delivery systems for cancer therapiesNanoparticles for imaging and treating brain cancerDesign and optimization of lipid-modified poly(amidoamine) dendrimer coated iron oxide nanoparticles as probes for biomedical applications.Interactions and encapsulation of vitamins C, B3, and B6 with dendrimers in water.Metal Nanoshell - Capsule for Light-Driven Release of Small Molecule.Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Aquatic self-assembly of sixteen subunits into a 39-kDa dendrimer.Temperature-dependent higher order structures of the (Pro-Pro-Gly)₁₀-modified dendrimer.Clusters of ligands on dendrimer surfaces.Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.The baffling human body and the boundless nanomaterial boon-a trap for cancer crab.Hyperbranched dendritic nano-carriers for topical delivery of dithranol.STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsDendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokineticsQuantification of functionalised gold nanoparticle-targeted knockdown of gene expression in HeLa cellsImpact of nanotechnology in cancer: emphasis on nanochemopreventionNanotechnology-based approaches in anticancer researchpH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.Preferential accumulation within tumors and in vivo imaging by functionalized luminescent dendrimer lanthanide complexes.Dendrimers functionalized with membrane-interacting peptides for viral inhibition.Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.Determining molecular mass distributions and compositions of functionalized dendrimer nanoparticles.Design of stimuli-responsive dendrimers.Carbon nanotubes in cancer theragnosis.Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.Nanomaterials: applications in cancer imaging and therapy.Targeted photodynamic therapy--a promising strategy of tumor treatment.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.Bioceramics: from bone regeneration to cancer nanomedicine.Polyamidoamine dendrimers as gene delivery carriers in the inner ear: How to improve transfection efficiency.Dendrimer and cancer: a patent review (2006-present).Advanced drug delivery nanosystems (aDDnSs): a mini-review.Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.GATG dendrimers and PEGylated block copolymers: from synthesis to bioapplications.
P2860
Q24599399-D272F70F-482A-45AE-863D-22552C379936Q26999288-5B07AE53-9C62-4E27-8520-C24A3D44F096Q28085438-65B4B955-07B3-485E-A27E-F05725757409Q28393485-103370D8-F836-4C3B-91C1-DAFC46E90DA2Q28394053-30F1F1A8-B897-4316-9E78-6E19AEFD2241Q30917699-C8B0B6B8-27F6-4B8D-8AE9-A5F22B989376Q33557251-EEEAA0C2-C3BB-4B86-9320-807A838CA5F5Q33591348-CA2FFFD1-31CE-4DBB-A60D-14E0D3258696Q33734954-20574B3D-6D11-4A7C-876E-4D918E5F64E8Q33740696-07E7FDD0-F5D1-4253-A428-64D5C82CCE03Q33758702-70C877BA-CBE3-43D3-8965-F31BAEC34A21Q33807264-9CB47888-B144-4D3D-8F79-A7658C681A31Q33882982-917E7E6A-EA16-4899-81A1-8A56B1FD3440Q33910306-4459A6F1-3A4C-4FBC-8EE0-6FDF51F45D43Q34108716-C4FEBC1E-0E71-4A93-8FD2-15967F515A0BQ34675249-12602ACC-A0F5-43D8-8F21-6B82005E5D23Q35031755-BEFCFFA7-0A5E-46A7-8F75-50D9FBAE2BD7Q35175451-5058CA4E-6DA0-4D97-8B68-1F594A969850Q35187635-FD23E0DE-566B-4965-AC9C-053C2CA342AFQ35750624-4B6B497C-A72E-46EF-BBBC-A65A353FF1A5Q36168983-208398C6-F1EA-4623-AD78-14DD55D67B72Q36404430-49C716F6-EED7-4083-BB7C-A1C5C965234DQ36449401-68026CF1-6A04-4B2C-942A-A38D2FB36F9FQ36617825-F3A67E11-DF65-4171-B50C-1A7F628BC51AQ36702085-682D63C2-9C0C-493B-8323-E117DE5145F8Q37340127-FE05952C-6C19-49B9-AD33-2C03010F6C2FQ37679917-63E300F2-C68E-4076-9914-B574520AA371Q37805495-8428FA64-CB9C-48EB-A95E-F72AE7698059Q37834336-0F967E2A-BDAE-4C76-9055-AAD2E0E513E9Q37857064-2CF1A5B3-1DC6-4ACA-9951-20FB79359315Q37872626-7308DAEB-139F-4098-8C46-163B280F1523Q37886750-634EFBC7-8099-4A74-8AD7-DEA52CD15736Q37939967-4D9C19B7-E499-4F7F-938A-3B4335F860DBQ37947163-6D9E1DB6-576B-4C24-ACFA-65F0D6DB7197Q38043458-B5BBB321-6CD6-41DD-A22A-F985E64DE4FAQ38075898-689DFCFA-E14D-49F5-842D-FFC82A5A5552Q38153469-8C4FD1FB-5B39-441E-A7FE-19E72B434385Q38179927-53677DCC-34CF-40DC-931C-B5C06D0503C6Q38199152-0298A8B6-EDB4-4720-B527-65B439BFCEB2Q38227356-C9F9F504-4748-4A09-87E1-41F22786BE53
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dendrimers in oncology: an expanding horizon.
@en
Dendrimers in oncology: an expanding horizon.
@nl
type
label
Dendrimers in oncology: an expanding horizon.
@en
Dendrimers in oncology: an expanding horizon.
@nl
prefLabel
Dendrimers in oncology: an expanding horizon.
@en
Dendrimers in oncology: an expanding horizon.
@nl
P2093
P356
P1433
P1476
Dendrimers in oncology: an expanding horizon.
@en
P2093
Narendra Kumar Jain
Palanirajan Vijayaraj Kumar
Rakesh Kumar Tekade
P356
10.1021/CR068212N
P577
2009-01-01T00:00:00Z